Press Releases

The miraDry system is FDA-cleared for the treatment of unwanted underarm sweat and odor, as well as the permanent removal of unwanted underarm hair. Outside the U.S., the miraDry system is intended for use by health care professionals for treatment of primary axillary hyperhidrosis in adults. Patient results and experience may vary. miraDry^®, miraDry fresh^TM, miraDry Experiences^TM, freshConnect^TM, freshRewards^TM and mD Concierge^TM are trademarks of miraDry, Inc. Products may be covered by one or more U.S. Patents. Please click here to see patents associated with individual miraDry, Inc. products.

miraDry, Inc. is a subsidiary of Sientra

This website uses cookies and other technologies to enhance site navigation, analyze site usage and assist in marketing efforts. You may find out more about our use of cookies in our Privacy Statement. By continuing to use this site you accept our use of cookies.

Sientra to Acquire Miramar Labs^®

Miramar Labs, Inc. ® Reports Q1 2017 Financial Results

Miramar Labs, Inc.^® Reports Fourth Quarter and Full Year 2016 Financial Results

Miramar Labs, Inc.^® to Present at the 9th Annual LD Micro Main Event

Miramar Labs, Inc.^® to Present at Two Investor Conferences in November 2016

Miramar Labs, Inc. ^® Reports Record Third Quarter 2016 Financial Results

Miramar Labs, Inc.^® Receives U.S. FDA 510(k) Clearance for Reduction of Odor

Miramar Labs, Inc. to Present at Ladenburg Thalmann 2nd Annual Healthcare Conference

Miramar Labs’ miraSmooth Procedure Featured on The Rachael Ray Show

Miramar Labs’ CEO Interviewed on Bloomberg Radio

About miraDry, Inc.

For Physicians

Connect With Us